WebA couple of brokers weighed in on the CSL share price during the final months of 2024. Leading Australian investment firm, Morgans raised its 12-month price target by 3.2% to $334.70 for CSL ... WebThe $750 million share purchase plan opens to Australian and New Zealand CSL shareholders on 21 December and closes 7 February. The US$4.5 billion institutional share placement completed last Thursday. I received this notice from CSL about their SPP. $273 is not a bad price, which is below market rate.
Why analysts are betting on a lift in the CSL share price?
WebA live view of the top 20 largest shareholders invested in CSL. We focus on rare and serious diseases and influenza vaccines. Today, we compete on the global stage as one of the largest and fastest-growing protein-based biotechnology businesses and a leading provider of in-licensed vaccines. ... Totals: Top 20 holders of ORDINARY FULLY PAID ... WebDec 21, 2024 · Here's what you need to know about CSL's share purchase plan The post Interested in the $750m CSL (ASX:CSL) share purchase plan? Here are the details appeared first on The Motley Fool Australia. curly toys
CSL embraces diversity with kidney care - Intelligent Investor
WebDec 17, 2024 · Hence the -8% fall in CSL shares yesterday reflected the market’s determination of the value of the acquisition, looking ahead, and the impact of dilution on the existing share price. ... Existing shareholders can participate in the accompanying Share Purchase Plan, or buy from an institution unloading some of the new shares it stuck its … WebApr 11, 2024 · Market Average Movement. 8.4%. 10% most volatile stocks in AU Market. 14.9%. 10% least volatile stocks in AU Market. 3.5%. Stable Share Price: CSL is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 2% a week. Volatility Over Time: CSL's weekly volatility (2%) has been stable over the past year. WebDec 15, 2024 · The company will also undertake a $750 million share purchase plan. After 12 days of speculation, CSL officially announced its $16.4 billion bid for Switzerland’s Vifor Pharma on Tuesday afternoon. curly to straight hair treatment